Glaxosmithkline | SCHULD

Aktienkurs
60.23
Täglich Wechseln
11.94 24.73%
Monatlich
23.65%
Jährlich
67.12%
Q1 Prognose
59.04




SCHULD Veränderung Datum
AbbVie USD 1000K 70.48B 2025-09
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 32.84B 1.19B 2025-06
Aurora Cannabis CAD 100.34M 1.29M 2025-09
Bausch Health Companies USD 21.74B 228M 2025-06
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Canopy Growth CAD 259.33M 68.47M 2025-09
Corcept Therapeutics USD 6.6M 2.03M 2025-06
Drreddys Laboratories INR 67.73B 19.09B 2025-12
Eli Lilly USD 42.51B 2.6B 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
J&J USD 45.8B 4.97B 2025-09
Merck USD 41.37B 5.97B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Pacira USD 376.72M 203.77M 2025-09
Perrigo USD 3.65B 454.7M 2025-06
Pfizer USD 60.85B 78M 2025-09
Prestige Brands USD 1.04B 1.7M 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 21.76B 530M 2025-09
Supernus Pharmaceuticals USD 31.77M 531K 2025-06
Takeda JPY 4.85T 208B 2025-12
Teva Pharmaceutical Industries USD 17.07B 450M 2025-09
Zoetis USD 6.79B 1.11B 2025-06


Glaxosmithkline SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.